The 10-day moving average for RKNEF crossed bearishly below the 50-day moving average on December 11, 2024. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
The Momentum Indicator moved below the 0 level on December 11, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on RKNEF as a result. In of 53 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
RKNEF moved below its 50-day moving average on December 11, 2024 date and that indicates a change from an upward trend to a downward trend.
The 50-day moving average for RKNEF moved below the 200-day moving average on December 13, 2024. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RKNEF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (31.038). P/E Ratio (87.719) is within average values for comparable stocks, (160.694). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.755). Dividend Yield (0.000) settles around the average of (0.084) among similar stocks. P/S Ratio (0.477) is also within normal values, averaging (58.073).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RKNEF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
Industry PackagedSoftware
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MCHI | 47.22 | 0.62 | +1.33% |
iShares MSCI China ETF | |||
MARW | 31.16 | -0.03 | -0.08% |
AllianzIM U.S. Large Cp Buffer20 Mar ETF | |||
AOK | 38.07 | -0.04 | -0.10% |
iShares Core Conservative Allocation ETF | |||
JULW | 35.36 | -0.04 | -0.12% |
AllianzIM US Large Cap Buffer20 Jul ETF | |||
CNCR | 12.66 | -0.15 | -1.20% |
Range Cancer Therapeutics ETF |
A.I.dvisor indicates that over the last year, RKNEF has been loosely correlated with JAXAF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if RKNEF jumps, then JAXAF could also see price increases.
Ticker / NAME | Correlation To RKNEF | 1D Price Change % | ||
---|---|---|---|---|
RKNEF | 100% | N/A | ||
JAXAF - RKNEF | 39% Loosely correlated | N/A | ||
CORZ - RKNEF | 38% Loosely correlated | -3.20% | ||
SQNNY - RKNEF | 33% Poorly correlated | -5.73% | ||
VRTC - RKNEF | 32% Poorly correlated | N/A | ||
APPIF - RKNEF | 30% Poorly correlated | N/A | ||
More |